- Home
- RDHL vs GXAI Comparison
RDHL vs GXAI Comparison
Compare RDHL & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDHL
- GXAI
- Stock Information
- Founded
- RDHL 2009
- GXAI 2021
- Country
- RDHL Israel
- GXAI United States
- Employees
- RDHL 53
- GXAI N/A
- Industry
- RDHL Biotechnology: Pharmaceutical Preparations
- GXAI
- Sector
- RDHL Health Care
- GXAI
- Exchange
- RDHL Nasdaq
- GXAI Nasdaq
- Market Cap
- RDHL 6.8M
- GXAI 7.5M
- IPO Year
- RDHL N/A
- GXAI 2023
- Fundamental
- Price
- RDHL $5.23
- GXAI $1.79
- Analyst Decision
- RDHL
- GXAI
- Analyst Count
- RDHL 0
- GXAI 0
- Target Price
- RDHL N/A
- GXAI N/A
- AVG Volume (30 Days)
- RDHL 10.4K
- GXAI 608.1K
- Earning Date
- RDHL 04-07-2025
- GXAI 03-26-2025
- Dividend Yield
- RDHL N/A
- GXAI N/A
- EPS Growth
- RDHL N/A
- GXAI N/A
- EPS
- RDHL N/A
- GXAI N/A
- Revenue
- RDHL $3,707,000.00
- GXAI $2,979.00
- Revenue This Year
- RDHL $224.90
- GXAI N/A
- Revenue Next Year
- RDHL $82.69
- GXAI N/A
- P/E Ratio
- RDHL N/A
- GXAI N/A
- Revenue Growth
- RDHL N/A
- GXAI N/A
- 52 Week Low
- RDHL $5.20
- GXAI $1.01
- 52 Week High
- RDHL $20.28
- GXAI $19.20
- Technical
- Relative Strength Index (RSI)
- RDHL 31.92
- GXAI 49.83
- Support Level
- RDHL $5.52
- GXAI $1.41
- Resistance Level
- RDHL $5.71
- GXAI $1.66
- Average True Range (ATR)
- RDHL 0.27
- GXAI 0.16
- MACD
- RDHL -0.04
- GXAI 0.04
- Stochastic Oscillator
- RDHL 2.38
- GXAI 67.69
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.
About GXAI Gaxos.ai Inc.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.